# Effect of Activated Charcoal on Rivaroxaban Pharmacokinetics in Healthy Subjects

> **NCT02657512** · PHASE1 · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Saint Etienne** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** rivaroxaban
- **DRUG:** rivaroxaban and activated charcoal

## Key facts

- **NCT ID:** NCT02657512
- **Lead sponsor:** Centre Hospitalier Universitaire de Saint Etienne
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2016-02
- **Final completion:** 2016-04
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2016-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02657512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02657512, "Effect of Activated Charcoal on Rivaroxaban Pharmacokinetics in Healthy Subjects". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02657512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*